Health Legislation

This Decree approves the amended statutes of the Beninese pharmaceutical regulatory agency, now named “Beninese Agency for Medicines and other Health Products”.

The decree defines the health benefit package of the universal health insurance scheme.

These regulations were developed in the exercise of the powers conferred by sections 24, 30, 46)2), 47(5) and 50(1) of the Social Health Insurance Act, 2023, by the Cabinet Secretary for Health, in consultation with the Board for the Social Health Authority.

The Decree establishes the health benefit package covered under the Universal Health Insurance. The decree was published on 25 November 2023 in the Official Journal.

The Decree specifies the application of certain provisions of the law establishing the Universal Health Insurance Scheme, such as affiliation and registration, the insured person's card, care benefits covered, the assumption of responsibility for benefits, health care providers, among other aspects.

The Decree sets out the statutes of the Nigerian Pharmaceutical Regulatory Agency.

This Decree establishes and fixes the rules of organization and operation of the Senegalese Pharmaceutical Regulatory Agency (ARP)

This document provides the benefits package of the National Health Insurance Scheme as offered to its beneficiaries through private health providers.

The law creates the Burundian Authority for the Regulation of Medicines for Human Use and Food. The authority's general aim is to protect public health by promoting the quality and safety of products such as prefabricated and ambient foods, medicines for human use, cosmetics and dietary products containing active ingredients, herbal medicines, traditional medicines, and medical devices, among others.

These Instructions establish the methodology to determine the community-based health insurance benefit package.

This law establishes a universal health insurance in the Togolese Republic.

The Decree approves the Organic Statute of the Autoridade Nacional Reguladora de Medicamento (The National Medicines Regulatory Authority). The purpose of this Decree is to define the rules governing the organization, management and operation, as well as the powers of its bodies.

The Decree establishes free access to family planning care and services in Burkina Faso (art.1). These are provided in public health facilities by community health workers (art.2). Private facilities can choose to implement the same, but need to sign an agreement with the Ministry of Health to settle the conditions and modalities (art.3). Specific services covered are to be determined by a joint order from the Ministers responsible for Health and Finances (art.4). These measures are financed by the budget of the State and partners (art. 5) and will be realized progressively (art. 6).

This Act establishes the Pharmacy and Medicines Regulatory Authority; provides for the functions and powers of the Authority; and provides for matters connected therewith and incidental thereto.

This decree guarantees access to free delivery care in public health facilities.

The objective of the law is to establish an institutional framework for regulating the pharmaceutical sector to ensure market approval and use of pharmaceutical products that are accessible, safe, efficient, and of appropriate quality (art.2). It notably establishes the Authority for pharmaceutical regulation (Autorité Ivoirienne de Regulation Pharmaceutique - AIRP) and addresses its mandates (chapter 1).

This Act repeals and replaces the National Pharmaceutical Procurement Unit Act, 2012 to establish the National Medical Supplies Agency as a public service agency responsible for the procurement, warehousing and distribution of drugs and medical supplies in a transparent and cost-effective manner for and on behalf of all public institutions throughout Sierra Leone.

This Law establishes the Universal Health Insurance Scheme Universal (RAMU) in the Republic of Benin.

This law introduces free healthcare for pregnant women and children under 5 throughout Burkina Faso.

This Act provides for the establishment of a Medicines Regulatory Authority; for the registration of medicines and medical devices; for the control of medicines and scheduled substances, and for incidental matters.